TORONTO & RIO DE JANEIRO--(BUSINESS WIRE)-- Arcadea Group, a preeminent, long-term investor in global software businesses, today announced the acquisition of Sofis, a leading provider of mission-critical software to the Brazilian healthcare sector, focused on hemotherapy and cell therapy.

Founded in Rio de Janeiro in 1986 by Reynaldo Mendes, Sofis’ product portfolio includes Hemote Plus for blood bank and transfusion services management, Cellvida for cell therapy, Salute for hospital management, and solutions across diagnostic medicine, ERP, and business intelligence. Sofis serves more than 300 institutions across Brazil — including hospitals, clinics, laboratories, blood centers, and public healthcare agencies — and its software supports approximately 75,000 blood collections and 150,000 transfusions every month.

Sofis Partners with Arcadea Group

Business Wire